Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pulmokine

Pulmokine
2007 FOUNDED
PRIVATE STATUS
2ndary - Private LATEST DEAL TYPE
3 INVESTORS
Description

Developer of biopharmaceutical therapies designed to treat pulmonary arterial hypertension (PAH) and related disorders. The company's pulmonary disease and kinase inhibitor technology treats crucial lung conditions, enabling patients suffering from lung diseases to access pulmonary drugs.

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 7 University Place
  • Room B127
  • Rensselaer, NY 12144
  • United States

+1 (518) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Pulmokine’s full profile, request a free trial.

Pulmokine Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 000 Completed Generating Revenue
5. Grant 01-Jan-2017 00000 000 Completed Generating Revenue
4. Grant 01-Jan-2016 00.000 000 Completed Generating Revenue
3. Seed Round 04-Mar-2015 000 000 Completed Generating Revenue
2. Debt - General 01-Oct-2014 Completed Generating Revenue
1. Grant 27-Mar-2014 $1.5M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Pulmokine Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
National Heart, Lung and Blood Institute Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0

Pulmokine Executive Team (5)

Name Title Board
Seat
Contact
Info
Lawrence Zisman Founder, Chief Executive Officer & President
Ron Wolff Ph.D Vice President of Regulatory Affairs and Toxicology
Aaron Waxman MD Scientific Advisor
Rubin Tuder MD Scientific Advisor

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Pulmokine Board Members (2)

Name Representing Role Since Contact
Info
Shreefal Mehta Ph.D Self Board Director 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »